Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
SUSPENDED
NCT05866679
PHASE1

Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging

Sponsor: M.D. Anderson Cancer Center

View on ClinicalTrials.gov

Summary

To learn if an MRSI can be performed on a 3T scanner using an investigational contrast drug called hyperpolarized 13-C pyruvate. 3T refers to the "strength" of the MRI machine.

Key Details

Gender

FEMALE

Age Range

18 Months - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2024-04-12

Completion Date

2028-08-31

Last Updated

2026-04-15

Healthy Volunteers

No

Conditions

Interventions

DRUG

Hyperpolarized 13-C-pyruvate

Given by PO

Locations (1)

M D Anderson Cancer Center

Houston, Texas, United States